Quanta Dialysis Technologies

Quanta has developed an advanced haemodialysis system for use in the home and clinic. Our proprietary  cartridge-based system, SC+, is a portable and compact providing clinical efficacy utilising high flow rates typically used on traditional machines. SC+ is designed to offer ease-of-use and flexibility, facilitating self-care and supporting dialysis patients across the entire continuum of care. Quanta is privately owned and based in Alcester, UK. The Company was founded in 2008 as a spin out from the FTSE 100 engineering company IMI plc, with funding provided by a group of leading venture capital investors specialised in healthcare: Air Liquide, b-to-v Partners AG, IMI, Kuwait Life Sciences Company, NBGI Ventures, Seroba Kernel LifeSciences, Seventure Partners and Wellington Partners.
Warwickshire, GB
68 (est)-1%

Quanta Dialysis Technologies Locations

Warwickshire, GB

Quanta Dialysis Technologies Metrics

Quanta Dialysis Technologies Summary

Founding Date


Total Funding

$57.5 M

Latest funding size

$2.89 M

Time since last funding

about 1 year


Quanta Dialysis Technologies News

Quanta Dialysis Technologies Company Life